Brief: Adaptimmune Therapeutics Reports Quarterly Loss Per Share Of $0.05
04/08/2022 12:52
Aug 4 (Reuters) - Adaptimmune Therapeutics PLC ADAP.O :
* ADAPTIMMUNE THERAPEUTICS PLC - QTRLY LOSS PER SHARE $0.05;
QTRLY
REVENUES $5.5 MILLION
* ADAPTIMMUNE THERAPEUTICS PLC SAYS REAFFIRMING FINANCIAL
GUIDANCE
Further company coverage: ADAP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adaptimmune Therapeutics
See all newsAdaptimmune Therapeutics PLC reports results for the quarter ended June 30 - Earnings Summary
Adaptimmune Therapeutics PLC expected to post a loss of 10 cents a share - Earnings Preview
Enters Settlement Agreement With MD Anderson - SEC Filing
Adaptimmune Therapeutics PLC reports results for the quarter ended March 31 - Earnings Summary
Adaptimmune Therapeutics PLC expected to post a loss of 12 cents a share - Earnings Preview